Nanjing King-Friend Biochemical Pharmaceutical Co. Ltd. announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 1,751.294 million compared to CNY 1,395.820 million a year ago. Operating income was CNY 624.488 million compared to CNY 457.450 million a year ago. Net income was CNY 555.521 million compared to CNY 408.474 million a year ago. Basic earnings per share from continuing operations was CNY 0.59 compared to CNY 0.44 a year ago. Diluted earnings per share from continuing operations was CNY 0.6 compared to CNY 0.44 a year ago.